YouareplanningacinicaLphase-l study inoncoloqy.testinganew chemotherapy in patients withamalignant
tumour.tisarandomised. placebo-controled.double-buindstudy Atotauof 100patients wilLreceive
standardtherapy and 100patients wil receivethenew substanceover a5-year treatment duration
Which statisticautest ismostappropriatetocomparethesurvivautimes betweenthetwoqroups?
Analvsisof variance(ANOVA
Chi-squaretest
Loq-ranktest
Pairedt-test
Unpairedt-test
@1MINNDOCRINE
